These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14723238)

  • 1. [The value of iron determination. Comment on Hermann Heimpel, Martin Riedel, Roman Wennauder, Lothar Thomas: Plasma iron determination--useful, unnecessary or misleading?].
    Teich N; Mossner J
    Med Klin (Munich); 2003 Jul; 98(7):398-9. PubMed ID: 14723238
    [No Abstract]   [Full Text] [Related]  

  • 2. Lessons from a survey of genotyping for hereditary haemochromatosis.
    Francis S; Thachil J
    J Clin Pathol; 2015 Jul; 68(7):578. PubMed ID: 25935547
    [No Abstract]   [Full Text] [Related]  

  • 3. HFE mutation analysis in patients with hepatitis C virus with positive screening for iron overload.
    Remacha AF; Carrasco M; Sardá MP; Barceló MJ; Baiget M
    Haematologica; 1999 Mar; 84(3):284-5. PubMed ID: 10189401
    [No Abstract]   [Full Text] [Related]  

  • 4. Review article: the modern diagnosis and management of haemochromatosis.
    Adams PC
    Aliment Pharmacol Ther; 2006 Jun; 23(12):1681-91. PubMed ID: 16817911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of screening for hemochromatosis.
    Dubois S; Kowdley KV
    Arch Intern Med; 2003 Nov; 163(20):2424-6; author reply 2426. PubMed ID: 14609776
    [No Abstract]   [Full Text] [Related]  

  • 6. Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population.
    Aleman S; Endalib S; Stål P; Lööf L; Lindgren S; Sandberg-Gertzén H; Almer S; Olsson S; Danielsson A; Wallerstedt S; Hultcrantz R
    Scand J Gastroenterol; 2011 Sep; 46(9):1118-26. PubMed ID: 21675821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferrin saturation and mortality.
    Benyamin B; Montgomery GW; Martin NG; Whitfield JB
    Clin Chem; 2011 Jun; 57(6):921-3; author reply 923. PubMed ID: 21343418
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis and management of hereditary haemochromatosis.
    Sood R; Bakashi R; Hegade VS; Kelly SM
    Br J Gen Pract; 2013 Jun; 63(611):331-2. PubMed ID: 23735405
    [No Abstract]   [Full Text] [Related]  

  • 9. Transferrin saturation should not be corrected for body mass index in screening studies for haemochromatosis.
    Thorstensen K; Asberg A
    J Hepatol; 2006 May; 44(5):1003-4. PubMed ID: 16551484
    [No Abstract]   [Full Text] [Related]  

  • 10. A patient with a rare cause of elevated troponin I.
    Kilias A; Klingel K; Gawaz M; Kramer U; Seizer P
    Clin Res Cardiol; 2015 Sep; 104(9):794-7. PubMed ID: 25916738
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for hemochromatosis.
    Crawford DH; Hickman P
    Hepatology; 2000 May; 31(5):1192-3. PubMed ID: 10796897
    [No Abstract]   [Full Text] [Related]  

  • 12. Population genetic screening for hereditary haemochromatosis: are we a step closer?
    Allen KJ
    Med J Aust; 2008 Sep; 189(6):300-1. PubMed ID: 18803529
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemochromatosis: when blood is too iron-rich.
    Harv Womens Health Watch; 2003 Oct; 11(2):1-3. PubMed ID: 14576008
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for hemochromatosis in a population with abnormal iron status.
    Veneri D; Krampera M; Zaffanello L; de Matteis G; Solero P; Franchini M
    Haematologica; 2003 May; 88(5):593-4. PubMed ID: 12745279
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
    De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C
    Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors.
    Adams PC; Kertesz AE; McLaren CE; Barr R; Bamford A; Chakrabarti S
    Hepatology; 2000 May; 31(5):1160-4. PubMed ID: 10796893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixture models of serum iron measures in population screening for hemochromatosis and iron overload.
    McLaren CE; Li KT; McLaren GD; Gordeuk VR; Snively BM; Reboussin DM; Barton JC; Acton RT; Dawkins FW; Harris EL; Eckfeldt JH; Moses GC; Adams PC
    Transl Res; 2006 Oct; 148(4):196-206. PubMed ID: 17002922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.